99 related articles for article (PubMed ID: 27860499)
41. Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: Management of steroid-exacerbated hyperglycemia.
Cheng YC; Guerra Y; Morkos M; Tahsin B; Onyenwenyi C; Fogg L; Fogelfeld L
PLoS One; 2021; 16(9):e0256682. PubMed ID: 34529703
[TBL] [Abstract][Full Text] [Related]
42. Comparison of oxidative stress markers in type 2 diabetes: basal bolus therapy versus twice daily premixed insulin analogs.
Sakamoto M; Inoue G; Tsuyusaki K; Usui K; Watanabe M; Irie J; Atsuda K; Yamada S
Intern Med; 2010; 49(5):355-9. PubMed ID: 20190465
[TBL] [Abstract][Full Text] [Related]
43. Comparison of Human Premixed and Basal Plus Short-Acting Insulin Regimens for Individuals With Type 2 Diabetes During Ramadan Fasting.
Altemimi MT; Odhaib SA; Imran HJ; Alhamza A; Almomin A; Mansour AA
Cureus; 2020 Dec; 12(12):e11976. PubMed ID: 33425548
[TBL] [Abstract][Full Text] [Related]
44. Continuation of evolution: Headliner glargine U300.
Soyaltin UE; Şimşir IY; Çetinkalp Ş
Med Hypotheses; 2018 Oct; 119():24-25. PubMed ID: 30122485
[No Abstract] [Full Text] [Related]
45. Impact of a pharmacy-based glucose management program on glycemic control in an inpatient general medicine population.
Efird LE; Golden SH; Visram K; Shermock K
Hosp Pract (1995); 2014 Feb; 42(1):101-8. PubMed ID: 24566602
[TBL] [Abstract][Full Text] [Related]
46. Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal-Bolus Insulin Regimen: A Prospective Randomized Study.
Batule S; Ramos A; Pérez-Montes de Oca A; Fuentes N; Martínez S; Raga J; Pena X; Tural C; Muñoz P; Soldevila B; Alonso N; Umpierrez G; Puig-Domingo M
J Clin Med; 2022 May; 11(10):. PubMed ID: 35628938
[TBL] [Abstract][Full Text] [Related]
47. Sustained improvement of glycemic control by insulin treatment after 9 years in patients with type 2 diabetes and secondary failure.
Lindström T
Diabetes Care; 1999 Aug; 22(8):1373-4. PubMed ID: 10480787
[No Abstract] [Full Text] [Related]
48. Effectiveness of a computerized insulin order template in general medical inpatients with type 2 diabetes: a cluster randomized trial.
Wexler DJ; Shrader P; Burns SM; Cagliero E
Diabetes Care; 2010 Oct; 33(10):2181-3. PubMed ID: 20664017
[TBL] [Abstract][Full Text] [Related]
49. Glycemic Effects of Once-a-Day Rapid-Acting Insulin Analogue Addition on a Basal Insulin Analogue in Korean Subjects with Poorly Controlled Type 2 Diabetes Mellitus.
Choe EY; Lee YH; Lee BW; Kang ES; Cha BS; Lee HC
Diabetes Metab J; 2012 Jun; 36(3):230-6. PubMed ID: 22737663
[TBL] [Abstract][Full Text] [Related]
50. Impact of Timing Between Insulin Administration and Meal Consumption on Glycemic Fluctuation and Outcomes in Hospitalized Patients With Type 2 Diabetes.
Lim SF; Jong M; Chew DEK; Lee JY
J Pharm Pract; 2020 Aug; 33(4):449-456. PubMed ID: 30585104
[TBL] [Abstract][Full Text] [Related]
51. Effect of a Mobile Health Technology-Based Diabetes Education Program on Glucose Control in Patients With Type 2 Diabetes Initiating Premixed Insulin: A Prospective, Multicenter, Observational Study.
Chen S; Lu J; Peng D; Liu F; Lu W; Zhu W; Zhou J; Jia W
Diabetes Care; 2023 Jan; 46(1):e6-e7. PubMed ID: 36399717
[No Abstract] [Full Text] [Related]
52. Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients.
Garg R; Schuman B; Hurwitz S; Metzger C; Bhandari S
BMJ Open Diabetes Res Care; 2017; 5(1):e000394. PubMed ID: 28405346
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation of the effectiveness of a protocol designed to improve glycemic control in hospitalized internal medicine patients with hyperglycemia].
Sáenz Abad D; Gimeno-Orna JA; Sierra-Bergua B; Lahoza-Pérez MC; Pérez-Calvo JI
An Sist Sanit Navar; 2015; 38(3):397-408. PubMed ID: 26786368
[TBL] [Abstract][Full Text] [Related]
54. Inpatient Use of Computer-Guided Insulin Devices Moving into the Non-Intensive Care Unit Setting.
Gianchandani R; Umpierrez GE
Diabetes Technol Ther; 2015 Oct; 17(10):673-5. PubMed ID: 26355754
[No Abstract] [Full Text] [Related]
55. Analysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemia.
Gao J; Xiong Q; Miao J; Zhang Y; Xia L; Lu M; Zhang B; Chen Y; Zhang A; Yu C; Wang LZ
Biomed Rep; 2015 May; 3(3):284-288. PubMed ID: 26137223
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of a hyperglycemia treatment program in a Vascular Surgery Department supervised by Endocrinology.
Caimari F; González C; Ramos A; Chico A; Cubero JM; Pérez A
Cir Esp; 2016; 94(7):392-8. PubMed ID: 25882331
[TBL] [Abstract][Full Text] [Related]
57. Determinants of initial insulin therapy for hospitalized patients with diabetes mellitus.
Chiang HH; Surampudi P; Sood A
J Diabetes Complications; 2022 Oct; 36(10):108307. PubMed ID: 36116360
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of Basal Insulin Dose Reductions in Hospitalized Patients With Diabetes While Unable to Eat.
Petite SE; Huenecke J; Tuttle N
Hosp Pharm; 2020 Aug; 55(4):246-252. PubMed ID: 32742013
[No Abstract] [Full Text] [Related]
59. Safe and Sufficient Glycemic Control by Using a Digital Clinical Decision Support System for Patients With Type 2 Diabetes in a Routine Setting on General Hospital Wards.
Lichtenegger KM; Aberer F; Tuca AC; Donsa K; Höll B; Schaupp L; Plank J; Beck P; Fruhwald FM; Kamolz LP; Pieber TR; Mader JK
J Diabetes Sci Technol; 2021 Mar; 15(2):231-235. PubMed ID: 32914640
[TBL] [Abstract][Full Text] [Related]
60. Differences in Glycemic Control in Diabetic and Non-diabetic Patients with Parenteral Nutrition Using a Basal plus Correction Insulin Regimen: An Observational, Retrospective Study.
Ramos A; Rabasa F; Mendoza L; Cardenete J; Gill P; Morilla A; Cardona D; Pérez A
Diabetes Ther; 2018 Jun; 9(3):1359-1367. PubMed ID: 29725969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
